We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.
Jennifer Gordon Recognized by The American Lawyer for Genentech Patent Victory
- January 21, 2022
Litigation counsel Jennifer Gordon was recognized by The American Lawyer’s “Litigation Daily” column for winning summary judgment for Genentech in patent litigation brought by Baxalta Inc. in the District of Delaware.
Baxalta targeted Genentech’s groundbreaking hemophilia treatment HEMLIBRA®. On January 13, the court found the patent Baxalta was asserting invalid for lack of enablement—a major win in this high-stakes dispute over Genentech’s blockbuster treatment. Also mentioned in the article were litigation partners Kenneth Gallo and Catherine Nyarady, counsel Josephine Young and associates Dave Cole, Naz Wehrli, Ariella Barel and Adrian Rabin.